Shak Steven 4
4 · GENOMIC HEALTH INC · Filed Sep 19, 2019
Insider Transaction Report
Form 4
Shak Steven
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-09-17$71.47/sh−25,000$1,786,692→ 58,795 total(indirect: By Trust)
Footnotes (4)
- [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2019.
- [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $71.24 to $71.91.
- [F4]Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.